Credit Suisse »

Black Diamond Therapeutics shares owned by Credit Suisse

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Credit Suisse from 13F filings

Historical chart of Credit Suisse investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Credit Suisse

Quarter filed Position value Share count Share price at filing
2024-03-31 $130k 26k 5.07
2023-12-31 $72k 26k 2.81
2023-09-30 $52k 18k 2.87
2022-06-30 $0 12 0.00
2021-12-31 $0 39k 0.00
2021-09-30 $408k 51k 8.07
2021-03-31 $225k 9.3k 24.18
2020-12-31 $760k 24k 31.94